HOME > ORGANIZATION
ORGANIZATION
- JMA to Host WMA Expert Conference on Revision of Helsinki Declaration in Tokyo on Feb. 28
February 20, 2013
- Biotech Association Asks MHLW to Include Drugs for Intractable Diseases and Orphan Drugs in Early Approval System
February 18, 2013
- JMA President Yokokura Opposes TPP Agreement, Expressing Concerns over Intervention in NHI Pricing
February 15, 2013
- PPTA President Airs Concern over Japanese Govt Intervention in Price Setting of Blood Products
February 13, 2013
- RAD-AR Council to Set Guidelines for Information Provisioning on Ethical Drugs
February 12, 2013
- JMA Exec. Mikami Wants a Hold on Info Disclosures Based on Transparency Guidelines
February 8, 2013
- Permanent Introduction of Premium for New Drug Development One of PhRMA’s “Priorities in 2013”: Japan Chair
February 5, 2013
- JMA Submits Petition Calling on MHLW to include 7 Vaccines in Public Vaccination Program
February 1, 2013
- Wholesale Industry FTC Prohibits Drink Donations at Academic Confabs, Keeps Pace with Drug Makers
January 31, 2013
- Number of CMRs on the Increase, Reaching 3,365: JCSOA Survey
January 30, 2013
- 1st MR Qualification Exam under New Education and Training System Attains 81.3% Pass Rate
January 29, 2013
- Wholesale Industry FTC Curbs Returns of Drugs to Be Discarded
January 29, 2013
- JMA Establishes Council to Discuss Transparency Guidelines, Will JPMA Be Able to Put Doctors’ Concerns to Rest?
January 29, 2013
- Drug Damage Watchdog Calls for Online OTC Drug Sales Ban in Principle
January 28, 2013
- JGA President Sawai Promises to Ensure Quality and Secure Stable Supply of Generics
January 24, 2013
- JPMA Bolstering ICH Activities to Propose New Topics from Industry
January 18, 2013
- JPMA Approves New “Code of Practice”
January 18, 2013
- JPA Expresses Deep Regrets over Court Ruling on Online Sale of OTC Drugs
January 16, 2013
- JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers
January 15, 2013
- JMA Sets Up “Council on Medical COI” Out of Concerns Over Transparency GL
January 11, 2013
ページ
As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…